How Much Residual Plasma May Cause TRALI?
Our cases suggest that the residual plasma volume as small as 10-20 mL containing donor derived WBC antibodies may cause TRALI.
World's Largest Resource for Cardiovascular Perfusion
Our cases suggest that the residual plasma volume as small as 10-20 mL containing donor derived WBC antibodies may cause TRALI.
A hyperactive immune response has been implicated in COVID-19 respiratory failure. Hemofiltration with a membrane designed to remove cytokines offers a potential avenue for treatment.
Heart failure can be the result of a wide range of disorders, including coronary ischemic heart disease, myocardial diseases, and valvular heart disease. Specific treatments address the underlying pathophysiology of the disorder. By reviewing hemodynamic and pressure-volume relationships in disease, we can think about tailoring our therapy to the needs of the patient (46:14 minutes).